| Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study (NCT07020247) | West China Hospital | 2024-11-19 |
| A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pouchitis (NCT06443502) | Takeda | 2024-11-19 |
| Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer (NCT06641635) | Peking Union Medical College Hospital | 2024-11-19 |
| Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q Mutation (NCT06956001) | Allist Pharmaceuticals, Inc. | 2024-11-19 |
| DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations (NCT06988475) | Cancer Research UK | 2024-11-19 |
| A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5% in Patients With Acne Vulgaris (GEDACNE 2) (NCT07384208) | PPM Services S.A. | 2024-11-19 |
| A Study to Demonstrate the Effect of REGN5713-5715 on Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Birch Pollen Allergy (NCT06602739) | Regeneron Pharmaceuticals | 2024-11-19 |
| Selective Neck Dissection Versus Modified Neck Dissection in PTC (NCT06554652) | Fudan University | 2024-11-19 |
| BladdEr Full OR Empty for Pelvic Radiation Therapy (NCT06651697) | University of California, San Diego | 2024-11-19 |
| An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis (NCT06435312) | UCB Biopharma SRL | 2024-11-19 |
| Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemia (NCT07514936) | Chinese PLA General Hospital | 2024-11-18 |
| A Study to See How Well and How Safely Different Treatments Work in a Group of Participants With Non-Small Cell Lung Cancer (NSCLC) (NCT06624059) | Hoffmann-La Roche | 2024-11-18 |
| A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) (NCT06672549) | Eli Lilly and Company | 2024-11-18 |
| Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus (NCT04670666) | EMS | 2024-11-18 |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) (NCT06692738) | AstraZeneca | 2024-11-18 |
| A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities (NCT06672939) | Eli Lilly and Company | 2024-11-18 |
| Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of Age (NCT06694389) | ModernaTX, Inc. | 2024-11-18 |
| Lateral Cord Magnetic Stimulation For Refractory Spastic Cerebral Palsy (NCT03676439) | Sociedad Argenttina de Neuromodulación | 2024-11-18 |
| A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With Osteoporosis (NCT06804590) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2024-11-16 |
| A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia (NCT06568471) | Hasten Biopharmaceutical Co., Ltd. | 2024-11-16 |
| A Study of HS-20094 in Chinese Adults With Overweight or Obesity (NCT06839664) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2024-11-16 |
| Canagliflozin Targeting Vascular Inflammation (NCT05427084) | Ottawa Heart Institute Research Corporation | 2024-11-15 |
| Obeticholic Acid Among Chronic HBV Patients with Hepatic Steatosis : Clinical and Portal Doppler Outcomes (NCT06691412) | Assiut University | 2024-11-15 |
| The Incidence of Post-Operative Lung Atelectasis With Erector Spinae Plane Block in Bariatric Surgery: (NCT06695858) | Kasr El Aini Hospital | 2024-11-15 |
| A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine (NCT06616194) | Pfizer | 2024-11-15 |
| Evaluating a Nitric Oxide Generator, Nebivolol as a Disease Modifier in Patients With Diabetic Neuropathy. (NCT06201611) | St. John's Research Institute | 2024-11-15 |
| RolloverTreatment With Triumeq for People With ALS Following the Lighthouse II Trial (NCT06658977) | Macquarie University, Australia | 2024-11-15 |
| FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients. (NCT06733038) | Gruppo Oncologico del Nord-Ovest | 2024-11-15 |
| Bupivacaine and Epinephrine Injection Study (NCT06456255) | Amin Javer | 2024-11-15 |
| Carvedilol and Alverine in Portal Hypertension (NCT06696248) | Shanghai Changzheng Hospital | 2024-11-15 |
| A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE) (NCT06680921) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2024-11-14 |
| Efficacy and Safety of Roflumilast Cream 0.3% in Subjects With Plaque Psoriasis: a Phase 3 Study (NCT06648772) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2024-11-14 |
| Efficacy and Safety of Platelet-rich Plasma, Metformin and Cryotherapy in Treatment of Non-genital Warts (NCT06691542) | Assiut University | 2024-11-14 |
| ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis (NCT06775860) | Beijing InnoCare Pharma Tech Co., Ltd. | 2024-11-14 |
| Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 in Patients Who Require Parenteral Nutrition (NCT06625931) | Yuhan Corporation | 2024-11-14 |
| PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis (NCT06607627) | Alexion Pharmaceuticals, Inc. | 2024-11-13 |
| Antiemetic Fosaprepitant To Remedy Nausea and Vomiting (NCT06382012) | Montefiore Medical Center | 2024-11-13 |
| An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older (NCT06666491) | GlaxoSmithKline | 2024-11-13 |
| PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer (NCT06616532) | Biotheus Inc. | 2024-11-13 |
| A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia A (NCT06297655) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2024-11-12 |
| A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC (NCT06617416) | Akeso | 2024-11-12 |
| Thromboprophylaxis in Lower Limb Immobilisation (NCT06370273) | Queen Mary University of London | 2024-11-12 |
| Total RadIoTherapy of Oligometastatic caNcerS (NCT06587490) | University of California, San Diego | 2024-11-12 |
| LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis (NCT06632457) | Boehringer Ingelheim | 2024-11-12 |
| Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 Years (NCT06715891) | Materia Medica Holding | 2024-11-11 |
| A Study of Olverembatinib in SDH-deficient GIST. (NCT06640361) | Ascentage Pharma Group Inc. | 2024-11-11 |
| IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2) (NCT06647862) | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 2024-11-11 |
| Prophylactic Amnioinfusion for Prevention of Postpartum Hemorrhage (NCT06691945) | The University of Texas Health Science Center, Houston | 2024-11-11 |
| A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE) (NCT06719141) | Longboard Pharmaceuticals | 2024-11-11 |
| Necessity of Post-mastectomy Radiotherapy After Neoadjuvant Chemotherapy and Mastectomy (NCT05993559) | Gangnam Severance Hospital | 2024-11-11 |
| Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications (NCT06573008) | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | 2024-11-11 |
| Adjuvant Tebentafusp in High Risk Ocular Melanoma (NCT06246149) | European Organisation for Research and Treatment of Cancer - EORTC | 2024-11-11 |
| A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) (NCT06449651) | Janssen Research & Development, LLC | 2024-11-11 |
| Efficacy of Endothelin Receptor Antagonism in Coronary Artery Spasm (NCT06432452) | Radboud University Medical Center | 2024-11-11 |
| Confirmatory Study on the Efficacy and Safety of the Fixed-dose Combination of Desloratadine/Betamethasone Versus Desloratadine (NCT06916884) | Laboratorios Silanes S.A. de C.V. | 2024-11-11 |
| Effect of Perioperative Roxadustat in Elective Lumbar Interbody Fusion Surgery. (NCT06772272) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2024-11-10 |
| A Randomized Controlled Trial of a Web-based Platform for Cancer Pain Management (NCT06663956) | West China Hospital | 2024-11-10 |
| Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis (NCT06867991) | The First People's Hospital of Changzhou | 2024-11-08 |
| A Study Assessing Adverse Events and Disease Activity of Intravenously (IV) Infused Telisotuzumab Adizutecan in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer (NCT06614192) | AbbVie | 2024-11-08 |
| A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients (NCT06496971) | NaviFUS Corporation | 2024-11-08 |
| the Efficacy and Safety of HRS9531 Injection in Subjects With Type 2 Diabetes， Inadequately Controlled With Diet and Exercise Alone (NCT06650007) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2024-11-08 |
| Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes (NCT06825182) | Nanjing First Hospital, Nanjing Medical University | 2024-11-07 |
| A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers (NCT05893888) | Privo Technologies | 2024-11-07 |
| Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT) (NCT06548971) | Capital Medical University | 2024-11-07 |
| Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes (NCT06246799) | The University of Texas Health Science Center at San Antonio | 2024-11-07 |
| An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients With Hemophilia B (NCT06700096) | Biocad | 2024-11-07 |
| A Study to Demonstrate How Well REGN1908-1909 Works in Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Cat Allergy (NCT06602726) | Regeneron Pharmaceuticals | 2024-11-06 |
| 89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study (NCT06750419) | Telix Pharmaceuticals (Innovations) Pty Limited | 2024-11-06 |
| Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism (NCT06393868) | Ottawa Hospital Research Institute | 2024-11-06 |
| Azithromycin Prophylaxis for PRElabor CEsarean DElivery Trial (NCT06605118) | The George Washington University Biostatistics Center | 2024-11-06 |
| A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD) (NCT05582993) | Takeda | 2024-11-06 |
| A Study to Evaluate the Efficacy and Safety of HRG2010 in Parkinson's Disease With Motor Fluctuations (NCT06596876) | Jiangsu HengRui Medicine Co., Ltd. | 2024-11-06 |
| Efficacy and Safety of VDPHL01 in Males With AGA (NCT06724614) | Veradermics, Inc. | 2024-11-06 |
| Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants (NCT06575192) | AbbVie | 2024-11-05 |
| A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both (NCT06534411) | Novo Nordisk A/S | 2024-11-05 |
| A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases (NCT06076642) | Takeda | 2024-11-04 |
| A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis (NCT06640257) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2024-11-04 |
| A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis (NCT06672393) | Hansoh BioMedical R&D Company | 2024-11-04 |
| VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy (NCT05920343) | Ottawa Hospital Research Institute | 2024-11-04 |
| Promotion of RSV Immunization Through Multiple Efforts (NCT06640868) | Washington University School of Medicine | 2024-11-04 |
| Minimally Invasive Non-surgical Therapy With or Without Injectable Bone Putty (NCT06553222) | Al-Azhar University | 2024-11-04 |
| Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of Age (NCT06641180) | Sanofi Pasteur, a Sanofi Company | 2024-11-04 |
| A Randomized Clinical Trial to Evaluate the Effectiveness of Oral Potassium Citrate in Preventing Ureteral Stent Encrustation in Patients Undergoing Ureteroscopy for Uric Acid Kidney Stones (NCT06819553) | Zagazig University | 2024-11-03 |
| Effectiveness and Safety of Zingiber Officinale Transdermal Patch for Acne Vulgaris; Study of Interleukin 1 and Skin Microbiome (NCT06787222) | Hasanuddin University | 2024-11-03 |
| Oral Intake of Mg in Controlled Asthmatic Patients (NCT06721247) | Zagazig University | 2024-11-02 |
| Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children (NCT06070350) | Philip Spinella | 2024-11-01 |
| Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT) (NCT06647563) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2024-11-01 |
| A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity (NCT06662383) | Eli Lilly and Company | 2024-11-01 |
| Trial of Reduced Alteplase Dose for Parapneumonic Effusion (TRAPPE) (NCT05766124) | Chinese University of Hong Kong | 2024-11-01 |
| Clinical and Radiographic Evaluation of Bioceramic Putty MTA Versus MTA in Pulpotomy of Immature Permanent Molars (NCT06219824) | Cairo University | 2024-11-01 |
| Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus (NCT06616961) | Popular Medical College Hospital | 2024-11-01 |
| Nicorandil as Anti-inflammatory in Rheumatoid Arthritis (NCT07516769) | Tanta University | 2024-11-01 |
| Platelet Transfusion in Critically Ill Patients With Thrombocytopenia (NCT06599385) | Assistance Publique - Hôpitaux de Paris | 2024-11-01 |
| Adjuvant PD-1 Blockade for High-risk Stage-II DMMR/MSI-H Colorectal Cancer (NCT06520683) | Sun Yat-sen University | 2024-11-01 |
| A Study of Olanzapine-Samidorphan Tablets in Adults With Schizophrenia (NCT06649214) | Qilu Pharmaceutical Co., Ltd. | 2024-11-01 |
| Rickettsia Clearance Study (NCT05972772) | Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit | 2024-11-01 |
| Planed Organ Preservation for Low Rectal Cancer After Neoadjuvant Chemotherapy (OPLAR) (NCT07070622) | West China Hospital | 2024-11-01 |
| Induction of Remission in Autoimmune Hepatitis With Azathioprine vs. MMF (NCT06650124) | Institute of Liver and Biliary Sciences, India | 2024-11-01 |
| Phase 3 Lot Consistency Study of Trivalent Hemagglutinin Nanoparticle Influenza Vaccine (NCT06485752) | Novavax | 2024-11-01 |
| Role of Dexmedetomidine as Synergistic Agent (NCT06662175) | Lady Reading Hospital, Pakistan | 2024-11-01 |